HIM
MEDP icon

Hanlon Investment Management’s Medpace MEDP Stock Holding History

Hanlon Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,396
Closed -$1.15M – 240
2026
Q1 		$1.15M Sell
2,396
-117
-5% -$59.9K 0.63% 35
2025
Q4 		$1.41M Buy
2,513
+1,016
+68% +$577K 0.78% 28
2025
Q3 		$770K Buy
+1,497
New +$654K 0.46% 75
2024
Q3 		– Sell
-2,383
Closed -$981K – 181
2024
Q2 		$981K Buy
2,383
+47
+2% +$18.6K 0.29% 59
2024
Q1 		$944K Sell
2,336
-201
-8% -$70.7K 0.29% 58
2023
Q4 		$778K Sell
2,537
-713
-22% -$192K 0.25% 59
2023
Q3 		$787K Buy
+3,250
New +$831K 0.24% 69

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Hanlon Investment Management's MEDP Position: Q2 2026 in Review

Hanlon Investment Management sold out of Medpace (MEDP) in Q2 2026, closing a stake of 2,396 shares — an estimated $1.15M sold.

Hanlon Investment Management first reported a position in MEDP in Q3 2023 and held it in 7 quarters. The position peaked at $1.41M in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Hanlon Investment Management reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Hanlon Investment Management sold 2,396 Medpace shares in Q2 2026, an estimated $1.15M.
  • Hanlon Investment Management first reported a position in Medpace in Q3 2023 and held it in 7 quarters.
  • Hanlon Investment Management's Medpace position peaked at $1.41M in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Hanlon Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.